ArticleBulletin du cancer2014

[Discovery of a new mutation in MYOD1 characterizes a subset of aggressive embryonal rhabdomyosarcoma partnering with mutations of the PI3K-AKT pathway].

Daniel OrbachPubMed ↗Publisher ↗

No numbers read from the abstract.